CLINICAL STUDIES

Cara CR845-210301

A Multicenter, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral CR845 in Chronic Kidney Disease Patients with Moderate-to-Severe Pruritus

Study Phase:

Phase 2

Criteria:

  • Male or Female 18 years or older
  • CKD patients with stage III, IV, or V disease